Skip to main content

Government News

 

Clinical courses

  • CDSCO releases regulatory guidelines for sampling of drugs, cosmetics and medical devices

    CDSCO releases regulatory guidelines for sampling of drugs, cosmetics & medical devices by drugs inspectors of central & state drug authorities. As per CDSCO, it will streamline and rationalize the sampling procedure of drugs, cosmetics & medical devices and maintain a centralized monthly database of Not of standard Quality (NSQ) or Spurious drugs to publish on CDSCO.

  • Union Finance Minister announces Vaccination to Prevent Cervical Cancer

    Aiming for Viksit Bharat by 2047 and with a sharp focus and providing momentum to Nari Shakti, Union Minister for Finance & Corporate Affairs, Smt. Nirmala Sitharaman today proposed vaccination to prevent Cervical Cancer and amalgamation of various schemes for maternal and child care, as she presented the Interim Budget 2024-25 in Parliament today.

  • Union Health Minister Dr Mansukh Mandaviya inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in Indore, Madhya Pradesh

    Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO) Sub Zonal office and Central Drug Testing Laboratory (CDTL) in Indore, Madhya Pradesh today.

  • WHO lanuches ICD-11, Traditional Medicine Module 2

    With the launch of ICD 11, Traditional Medicine Module 2 by the World Health Organization today, preparations have started for its implementation. The data and terminology relating to diseases based on Ayurveda, Siddha and Unani Medicine have been included in the WHO ICD-11 classification. With this effort, the terminology defining diseases in Ayurveda, Unani and Siddha medicine has been indexed as a code and included in the WHO Disease Classification Series ICD-11.

  • CDSCO recommends not to use anti-cold syrup in children

    CDSCO recommends widely used anti-cold syrup not to be used in children below 4 years of age, after recommendation from SEC.

    The FDC of Chlorpheniramine Maleate and Phenylephrine HCl was declared as rational by Prof. Kokate committee and based on the recommendation of the committee, this office has issued NOC for continued manufacturing and marketing of subject FDC on 17.07.2015 under the 18 months policy decision.

  • AAPP recommends changes in draft rules of National pharmacy commission Bill

    The Association of Advanced pharmacy practitioners (AAPP) strongly urges the government of India to change certain drafted rules of National pharmacy commission Bill. The recommendations of AAPP mainly focused on number of members in council, minimum qualification to registered as pharmacist and national level entrance examination to enter in pharmacy education.

  • PCI launched DIGI-PHARMed application for pharmacists

    The Pharmacy Council of India (PCI) will launch a revamped – DIGI-PHARMed application on December 1 with four integrated services having an objective to regulate the Pharmacy education in the country by enrollment/ registration of Pharmacy institutions/ Pharmacist/ Pharmacy student/ Pharmacist jobseeker across India.

  • Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member

    The Pharmacopoeial Discussion Group (PDG) announced the Indian Pharmacopoeia Commission (IPC) as a PDG member on October 5, 2023 during PDG Stakeholder’s meeting in Hyderabad. IPC officially joined as a member in the PDG at the PDG’s Annual Meeting which was held on October 3-4, 2023 in Hyderabad. The World Health Organization (WHO) also continues to serve as observer of the PDG.

  • Govt to include Oseltamivir and Zanamivir in Schedule H1

    Government to include Oseltamivir and Zanamivir in Schedule H1 after the consultation with the Drugs Technical Advisory Board.

  • National Policy on Research and Development and Innovation in Pharma-MedTech Sector

    “Today is a historic day, an inflection point in the journey of "Atmanirbharta" in the pharma & medical devices sector. We need to transform Indian Pharma & MedTech sectors from a cost-based to a value-based & innovation-based industry.” This was stated by Dr.

Subscribe to Government News